Navigation Links
New Ozone-Based Disinfection Technology Eradicates MRSA From Infected Hospital Rooms - In Less Than 60 Minutes

BELLEVILLE, Ontario, July 9, 2013 /PRNewswire/ -- San Francisco-based Medizone International (MZEI:OB MZEI:QB), is pleased to announce that it is using its AsepticSure system at the Quinte Health Care-Belleville General Hospital as part of the hospital's management of a recent outbreak of MRSA (Methicilllin-Resistant Staphylococcus Aureus) infections there.  This move comes in the wake of Medizone having previously disinfected several patient care rooms at the facility in as little as 40 minutes treatment-time per room.

Dr. Dick Zoutman, Chief of Staff at the hospital, stated "Dr. Michael Shannon and other team members have been performing AsepticSure disinfection treatments at our hospital.  These efforts have proven so successful that we have now fully implemented the AsepticSure protocols into the management of this most recent MRSA outbreak." 

Drs. Shannon and Zoutman are co-inventors of AsepticSure – a new disinfection system that mimics the actions of the human immune system in which antibodies generate ozone and hydrogen peroxide to produce a highly reactive compound called Trioxidane. This compound – toxic to bacteria, viruses and mold – is temporarily released into sealed hospital rooms in order to kill all pathogens present. The room is then returned to a fresh, clean, safe and residue-free state at the end of the process.

"This has been a long time in coming," said Dr. Shannon.  "We have now not only demonstrated the absolute safety of our AsepticSure process in an operational hospital setting, but have also shown its efficacy.  Comparing sampling results before and after several contaminated ward-rooms were treated, we have confirmed that a 100% bacterial kill is achievable, without normal ward activities being disrupted. 

"The same microbial kill rates have been repeatedly demonstrated in more controlled laboratory settings.  These results, achieved in a real-world health care setting, are nothing short of spectacular. We consider ourselves privileged to be able to work with staff from one of the finest hospitals in the Province and over time, are now very confident that our process will help make it the cleanest hospital on the continent."

Medizone International, Inc. is engaged in initial production of its modular design AsepticSure® Decontamination Systems. Decontamination to the sterilization standard of >6 log (99.9999%) is obtainable within hospitals, airlines, cruise ships, long term care facilities, food processing plants, clean room manufacturing facilities, schools and other critical infrastructure.

This Press Release may contain certain forward looking statements that could involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company's filings made with the Securities and Exchange Commission.

For press information on Medizone International, please contact:

Bruce Smeaton, Investor Relations, Medizone International, Inc.

T: 001-415-331-0202    E:

For more information, visit:


SOURCE Medizone International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Infection Control Market - Sterilization & Disinfection - Global forecast to 2017
2. Lumalier Helps Hospitals Improve Infection Control Efforts with Real-time Disinfection Data from New iTRU-D Technology and Web Portal System
3. New UV-C-Reflective Wall Coating Dramatically Reduces Disinfection Times for TRU-D Device
4. New CDC Study Confirms Effectiveness of UV-C Disinfection in Reducing Harmful Pathogens for Hospitals
5. New Disinfection Technology Expected To Combat Deadly CRE Threat
6. ARAMARK Healthcare Offered Disinfection Robot Revolutionizes Hospital Sanitation Practices on The Doctors
7. PDI Signs Agreement with HealthTrust for Surface Disinfection Products
8. Platine Pharma Services et Indicia Biotechnology se rapprochent pour renforcer leur leadership en immunomonitoring
9. Breast Imaging Technologies Market - Technology and Market Analysis & Global Forecasts to 2017
10. Shaw Regional Cancer Center Chooses RAD Technologys Temporary Radiotherapy Vault System To Provide Continuous Care To Patients During New Linear Accelerator Installation
11. PurThread Wins 2013 American Technology Award
Post Your Comments:
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ) today announced that ... York State Attorney General,s Office to end the ... statutes with the Attorney General over the decision of Forest ... selling the now generic version of memantine immediate release tablets.  ... released its counterclaims against New York , ...
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ), a ... start-up  biotechnology company focused on the development of ... by the F-Prime Biomedical Research Initiative (FBRI), today ... collaboration to support the discovery and development of ... Obsessive Compulsive disorders (OCD). ...
(Date:11/25/2015)... 2015 --> ... devices was valued at $11,171.1 million in 2014, and ... 5.7% during 2015 - 2022. The global market is ... of diabetes. In addition, the increase in obese population ... to the growth of the market. Furthermore, technological advancements ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... ... For the first time, Vitalalert is donating half of its earnings to ... between the two groups began in 2014 with Vitalalert pledging a portion of every ... founded in 1954 and is an international Christian-based health organization whose mission is to ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 25, 2015, ... for the Narconon network, announced the release of a new cutting edge recovery program ... organization has been working with drug- and alcohol-addicted individuals with the purpose to free ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for ... aware of the benefits of Botox® in the treatment of moderate facial wrinkling, few ... and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism ...
(Date:11/25/2015)... ... , ... In an ongoing Clinical Study conducted by an independent physician, Andrew ... is evaluating the efficacy of its product and its disinfection protocol. This study is ... May 2014 through October 2015 at a 360-bed, acute-care, academic medical center located in ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care for pulmonary ... Periwinkle Pioneers, nominated by the public, will receive special recognition throughout 2016 as ...
Breaking Medicine News(10 mins):